Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Curative Resected Prostate Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Oslo University Hospital
Sponsor:
Information provided by (Responsible Party):
Svein Dueland, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01197625
First received: September 7, 2010
Last updated: July 7, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2025
  Estimated Primary Completion Date: September 2019 (Final data collection date for primary outcome measure)